產(chǎn)品搜索
相關(guān)文章
- 重磅!科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 川大華西CRISPR研究再獲新進(jìn)展
- DKK-1細(xì)胞篩選模型
- 細(xì)胞株定期維護(hù)與監(jiān)測(cè)要做好哪些?
- 老靶點(diǎn)迭代突破創(chuàng)新:Her2靶點(diǎn)細(xì)胞模型
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 耳聾基因檢測(cè)標(biāo)準(zhǔn)品
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73252CSF3R T615A/BaF3

- 詳細(xì)內(nèi)容
CBP73252 | |
I. Introduction | |
Cell Line Name: | CSF3R T615A/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
CSF3R T615A lies within the extracellular domain proximal to the transmembrane domain of the Csf3r protein (PMID: 23656643). T615A is predicted to confer a gain of function to the Csf3r protein, as demonstrated by increased proliferation of transformed cells in culture (PMID: 23656643). | |
III. Representative Data | |
1.WB of CSF3R T615A/BaF3 | |
2. Anti-proliferation assay | |
Figure 2. Anti-proliferation assay of three reference compounds on the CSF3R T615A/BaF3. |